206 related articles for article (PubMed ID: 16182605)
1. Disease models of autoimmunity.
Ferguson CA
Trends Immunol; 2005 Nov; 26(11):557-8. PubMed ID: 16182605
[No Abstract] [Full Text] [Related]
2. Autoimmunity and the skin.
Kumar V; Beutner EH; Chorzelski TP
Concepts Immunopathol; 1985; 1():318-53. PubMed ID: 3916406
[No Abstract] [Full Text] [Related]
3. Idiotypic induction of autoimmunity.
Krause I; Blank M; Shoenfeld Y
J Biol Regul Homeost Agents; 1998; 12(3):49-52. PubMed ID: 9795831
[No Abstract] [Full Text] [Related]
4. Lupus-like autoimmunity in murine graft-versus-host disease.
Portanova JP; Kotzin BL
Concepts Immunopathol; 1988; 6():119-40. PubMed ID: 3292048
[No Abstract] [Full Text] [Related]
5. IL-18 and IL-18 receptors in the development of autoimmunity.
Bossù P; Del Giudice E; Ciaramella A; Neumann D; Boraschi D
Eur Cytokine Netw; 2000 Sep; 11(3):515-6. PubMed ID: 11203201
[No Abstract] [Full Text] [Related]
6. [Masking of pan-T-cell markers in patients with autoimmune diseases].
Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
[No Abstract] [Full Text] [Related]
7. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
Cohen Y; Nagler A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162
[No Abstract] [Full Text] [Related]
8. Shared autoimmunity: a concept for which the time has come.
Alarcón-Segovia D
Autoimmunity; 2005 May; 38(3):201-3. PubMed ID: 16126507
[No Abstract] [Full Text] [Related]
9. [Lymphocyte transformation in autoimmune skin diseases].
Mészáros C; Nagy E
Z Haut Geschlechtskr; 1969 Apr; 44(8):265-8. PubMed ID: 4188257
[No Abstract] [Full Text] [Related]
10. [Autoimmune diseases].
Deuel W; Siegenthaler-Zuber G; Siegenthaler W
Schweiz Rundsch Med Prax; 1988 May; 77(18):485-8. PubMed ID: 3051259
[No Abstract] [Full Text] [Related]
11. Overlap syndromes in the context of shared autoimmunity.
Rodríguez-Reyna TS; Alarcón-Segovia D
Autoimmunity; 2005 May; 38(3):219-23. PubMed ID: 16126510
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmunity.
Nussenblatt RB; Gunn HC; Ryffel B; Borel JF
Prog Allergy; 1986; 38():159-80. PubMed ID: 3487790
[No Abstract] [Full Text] [Related]
13. Immunity, autoimmunity and autoimmune diseases in older people.
Rosato E; Salsano F
J Biol Regul Homeost Agents; 2008; 22(4):217-24. PubMed ID: 19036223
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocytotoxic antibodies in autoimmune diseases].
Klingelhöfer HL; Malchow H; Havemann K; Börngen U
Verh Dtsch Ges Inn Med; 1972; 78():884-7. PubMed ID: 4665773
[No Abstract] [Full Text] [Related]
15. [Pathogenetic considerations in immunopathological systemic diseases].
Warnatz H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():712-8. PubMed ID: 25536
[No Abstract] [Full Text] [Related]
16. [Complement and its components in selected autoimmune diseases].
Pietruska Z
Pol Tyg Lek; 1980 Jan; 35(1):27-30. PubMed ID: 6154287
[No Abstract] [Full Text] [Related]
17. [Autoimmune and autoaggressive diseases].
Spier HW
Arch Klin Exp Dermatol; 1970; 237(1):18-26. PubMed ID: 5417105
[No Abstract] [Full Text] [Related]
18. Seronegative autoimmune diseases.
Alessandri C; Conti F; Conigliaro P; Mancini R; Massaro L; Valesini G
Ann N Y Acad Sci; 2009 Sep; 1173():52-9. PubMed ID: 19758132
[TBL] [Abstract][Full Text] [Related]
19. The danger model in deciphering autoimmunity.
Tveita AA
Rheumatology (Oxford); 2010 Apr; 49(4):632-9. PubMed ID: 20144928
[TBL] [Abstract][Full Text] [Related]
20. Scleroderma: from cell and molecular mechanisms to disease models.
Abraham DJ; Varga J
Trends Immunol; 2005 Nov; 26(11):587-95. PubMed ID: 16168711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
